Preeclampsia (PE), a pregnancy-specific multisystem vascular disorder, is globally responsible for many maternal and perinatal deaths and complications, as it affects 2%- 8% of pregnancies ([@B1]). It generally occurs during the second half of pregnancy and characterized by new-onset gestational hypertension, generalized vascular dysfunction and proteinuria ([@B2]). Etiology of the disease is still unclear, although it is hypothesized that PE can be resulted from placental malperfusion due to abnormal remodeling of maternal spiral arteries, and both of maternal and fetal components are involved in the development of the condition ([@B3]). Moreover, it is demonstrated that PE is associated with disturbance in the levels of [angiogenic](http://onlinelibrary.wiley.com/doi/10.1002/uog.10136/full) factors including soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) ([@B4], [@B5]). Furthermore, some studies showed that PE is related with increased levels of maternal circulating cytokines such as TNF- α, IFN- γ, IL- 10 and IL- 6 ([@B6], [@B7]). In the last two decades, there is growing evidence that bacterial, viral and parasitic infectious agents and their related inflammatory responses are implicated in the pathophysiology of PE ([@B1], [@B8], [@B9]). Cytomegalovirus (CMV), a ubiquitous beta herpes virus, is globally one of the most common congenital infectious agents during pregnancy.

CMV is responsible for a broad range of disabilities in newborns, such as visual impairment, sensorineural hearing loss, and motor and cognitive deficits. In pregnant women, clinical symptoms of CMV infection is generally nonspecific and resemble a mononucleosis- or flu-like syndrome, with fever, sore throat, cervical lymphadenopathy, myalgia, and fatigue ([@B10], [@B11]).

Moreover, it is demonstrated that CMV infection is a potential risk factor for the development of hypertension and cardiovascular disease ([@B12]). In the past two decades, several observational and experimental studies have investigated the possible relationship between CMV infection and the development of PE in pregnant women. However, the majority of studies demonstrated conflicting results together and to date, it remains unknown whether women with CMV infection are at increased of developing preeclampsia or not; therefore, for the first time we designed this systematic review and meta-analysis study in an attempt to a better understanding of a possible link between CMV infection and development of PE.

Methods
=======

**Study design:**For this meta-analysis study, we followed the PRISMA (preferred reporting items for systematic reviews and meta-analysis) guidelines for design, analysis and interpretation of results. The exposure for our study was serological or molecular evidence of CMV infection and the main outcome of interest was developing PE in infected women and compared with healthy controls. To prevent common biases during the literature research, language, geographical area or date restrictions were not applied. All observational (cross-sectional, cohort, or case--control) studies that evaluated the CMV infection status among women with PE and healthy controls were included in the present meta- analysis.

PE is defined as a systolic blood pressure ≥ 140 mm by the American College of Obstetricians and Gynecologists (ACOG) criteria ([@B13]) and CMV infection is measured by the detection of serum CMV-specific IgG or IgM using serological methods and DNA-based detection molecular methods. We excluded case- reports, experimental studies and non-original papers (review, systematic reviews, editorials, or letters).

**Search strategy and study selection:**A comprehensive literature search for identifying the relevant papers published earlier than February 2018 was performed in PubMed, ISI (Web of Science), Google Scholar and SCOPUS databases. Our search was done by using the combination of the following keywords: "Cytomegalovirus", "Cytomegalovirus infection", "CMV", "preeclampsia", "eclampsia", "gestosis", "pregnancy hypertension" and "gestational hypertension", with the Boolean operators "OR" and/or "AND". Finally, our search was complemented by reviewing the reference lists of the electronically retrieved full-text papers and related reviews. Our search strategy is schematically presented in the PRISMA flow diagram ([figure 1](#F1){ref-type="fig"} and supplementary [figure 1](#F1){ref-type="fig"}).

**Data extraction and study quality assessment:**After duplicate removal, two researchers (Z.G. and A.R) independently assessed the full text of eligible studies and information was extracted using Microsoft Excel software. The following information was extracted for each study: first author, publication year, country, study design, sample size, diagnostic method. In case-control studies, matching criteria, number of cases and controls and of infected subjects in each group were extracted.

Any uncertainties were resolved by joint review of the manuscript and consultation with third researcher (M.N.S) to reach consensus. Newcastle-Ottawa scale was used for quality assessment of the included studies, as it was used in our previously meta-analysis studies ([@B14], [@B8]). This step was also done by two researchers (Z.G. and A.R) and disagreements were resolved after consultation with third researcher (M.N.S).

**Data synthesis and statistical analysis:**In this study, meta-analysis was performed using Stata Version 12 (Stata Corp., College Station, TX). The association between CMV infection and PE was assessed through generating the pooled odds ratio (OR) and 95% confidence intervals (CI) using a random effects model.

In studies where adjusted ORs were presented, they were used in preference to crude odds ratio. To assess heterogeneity amongst the studies, Q-test and *I*^2^ methods were utilized. Stratified analysis was subsequently performed regarding the type of antibodies and methods (IgG, IgM and PCR). Publication bias was assessed through Egger's publication bias method for asymmetry.

A p*-*value of less than 0.1 was considered statistically significant. Results are presented as forest plots and the association between CMV infection and PE is illustrated by an OR and 95% CI.

![Flow chart showing the process of study selection](cjim-9-211-g001){#F1}

Results
=======

**Study characteristics:**As shown in PRISMA flowchart ([figure 1](#F1){ref-type="fig"}), our literature search yielded 2278 articles. After duplicate removal and assessment of the titles and abstracts, 19 studies were reviewed in full text. Of these, six studies were excluded after applying inclusion and exclusion criteria, and finally 13 articles met the eligibility criteria to be included in the meta-analysis (15-27). Among 13 included studies, eight had a case-control design and five were nested case-control studies. The eligible studies were performed in seven different countries from three continents (nine in America, three in Europe and one in Asia). Two studies were based on molecular methods, 11 studies used serological methods to detect CMV infection in cases and controls. Four studies included reported seroprevalence of CMV infection based on the detection of only IgG antibodies, three on IgM antibodies, and four studies screened both the IgG and IgM antibodies for CMV infection. A total of 2734 pregnant women with confirmed PE were included in these studies. All studies used ACOG criteria for the selection of preeclamptic women. As well, the included studies recruited a total of 3424 healthy pregnant women as controls. The main characteristics for included studies are presented in [table 1](#T1){ref-type="table"}.

**Prevalence of CMV infection among preeclamptic women and controls:**Overall, the prevalence of CMV infection in pregnant women with PE based on PCR, IgG and IgM were 40.6% (24/59), 58.8 (1123/1909), and 3.5% (89/2490), respectively. While, the prevalence of CMV infection in healthy controls based on PCR, IgG and IgM were 21.5% (14/65), 62.1% (1595/2566), and 3.5% (74/2099), respectively.

###### 

Summary of studies investigating the association between Cytomegalovirus infection and preeclampsia

  **First author/year**     **Ref**   **Country**   **Diagnostic Method**   **Cases**   **Controls**        **Quality score**                       
  ------------------------- --------- ------------- ----------------------- ----------- ------------------- ------------------- ------------------- ---
  Belfort, 1998                       USA           PCR                     33          10                  36                  2                   5
  Trogstad, 2001                      Noewey        IgG-ELISA               33          19                  945                 650                 7
  Carreiras, 2002                     Venezuela     PCR                     26          14                  29                  12                  6
  Dadelszen, 2003                     Canada        IgG-ELISA               38          30                  113                 92                  6
  Rustvuld, 2005                      USA           IgG-ELISA               48          21                  140                 60                  7
  Xie, 2010                           USA           IgG&IgM-ELISA           78          IgG, 41; IgM, 8     109                 IgG, 29; IgM, 7     7
  Strand, 2012                        Norway        IgG&IgM-ELISA           1470        IgG, 819; IgM, 18   991                 IgG, 578; IgM, 12   7
  Zhang, 2012                         China         IgM-ELISA               52          49                  34                  34                  5
  Haggerty, 2013                      USA           IgM-ELISA               509         7                   336                 4                   7
  Haggerty, 2013                      USA           IgM-ELISA               205         4                   423                 13                  5
  Xie, 2014                           USA           IgG&IgM-ELISA           30          IgG, 17; IgM, 3     60                  IgG, 22; IgM, 3     5
  Radulescu, 2016                     Romania       IgG-ELISA               66          40                  62                  26                  6
  Alvarado-Esquivel, 2017             Mexico        IgG&IgM-ELISA           146         IgG, 136; IgM, 0    146                 IgG, 138; IgM, 1    6

**Results of meta-analysis:**At first, we performed meta-analysis regarding the three different methods (PCR, IgG-ELISA and IgM-ELISA) used in the included studies for the detection of CMV infection between cases and controls. The results of meta-analysis based on PCR (OR: 3.09; 95% CI:0.72--13.24; I^2^=57.3%), IgG-ELISA (OR: 1.24; 95% CI:0.83--1.85; I^2^=71%) and IgM-ELISA (OR: 1.04; 95% CI:0.66--1.65; I^2^=0.0%) demonstrated that CMV infection could not be the potential risk factor for PE ([figure 2, A-C](#F2){ref-type="fig"}).

![Forest plots for the association between cytomegalovirus infection and preeclampsia. A) Forest plot regarding the PCR method, B) Forest plot regarding the IgG-ELISA method, C) Forest plot regarding the IgM-ELISA method](cjim-9-211-g002){#F2}

In subgroup analysis regarding the IgG antibody and type of studies, a significant relationship was observed in case-control studies (OR: 1.71; 95% CI:1.04--2.81; I^2^=54.7%), whereas this relationship was not significant in nested case-control studies (OR: 0.88; 95% CI:0.75--1.03; I^2^=0.0%) ([figure 3](#F3){ref-type="fig"}). Egger's test was used to detect the possibility of publication bias. Based on the symmetry assumption, there was no significant publication bias in the studies ([figure 4 A and B](#F4){ref-type="fig"}).

![Forest plots for the association between cytomegalovirus infection and preeclampsia, result of the subgroup analysis](cjim-9-211-g003){#F3}

![Publication bias using Egger's plot. (A) Publication bias related with IgG-ELISA method. (B) Publication bias related with IgM-ELISA method.](cjim-9-211-g004){#F4}

Discussion
==========

The results of this study demonstrated that women with PE have higher rate of CMV infection compared to healthy controls, although the statistically significant relationship was not observed. Specially we have found higher odds in studies that used PCR to detect CMV infection (OR=3.09), although the number of studies was very low (two studies). We guess if more molecular studies were available, it was possible that significant correlation would be found. Higher odds found in PCR studies could be due to higher sensitivity and specificity of PCR-based methods compared to serological methods.

Although it should be more investigated, since several potential mechanisms could be involved in the association between CMV infection and the development of PE. Endothelial-platelet dysfunction and acute atherosis in arterial wall resulting from CMV infection can lead to uteroplacental ischemia, a key pathogenic condition to the development of PE ([@B28], [@B29]). Further, CMV infection could stimulate the release of immune inflammatory mediators including, tumour necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), interleukines (IL-4, IL-8, IL-18), neutrophils and is related with upregulated expression of TLR-2, and TLR-4 ([@B26], [@B30]-[@B32]).

Several studies have demonstrated that the shift of immunological cytokine profile of Th2 toward Th1 and high levels of pro-inflammatory cytokines have important role in the onset of PE ([@B1], [@B33], [@B34]). Moreover, increasing evidence has shown that the extent of neutrophil activation and upregulated TLR expression can be linked with the pathogenesis of PE ([@B32], [@B35]).

In addition, it is demonstrated that CMV infection can modify adhesion molecules such as VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) and E-selectin which is related with the increase of matrix metalloproteinase (MMP-2) activity and fms-like tyrosine kinase-1 (sFlt-1), that can cause alteration in vessel remodeling, infiltration of inflammatory cells and the development of PE ([@B36], [@B26]).

The strength of our study includes rigorous methodology, the use of ACOG criteria to identify the cases in all studies, well-defined matching criteria for controls, and subgroup analysis considering the type of studies and diagnostic methods. Yet like our previous meta-analysis studies ([@B14], [@B8]), this study was limited by the fact that, low number studies with mostly low sample size were available in this issue. Additionally, most of the included studies have a case-control design, while other type of observational studies like cohorts could be more useful to better understand possible relationship. Another limitation is the fact that the results of the present meta-analysis are based on the data from studies with different methodological characteristics, and different cut-offs in serological methods, however we used random effects to overcome these limitations. Moreover, like our previous study on *Helicobacter pylori* and the developing of PE ([@B8]), the present study was also copied with regard to the results without adjustment for potential confounders in some included studies and restricted geographical areas (America, Europe and one study in Asia). Furthermore, since CMV infection is ubiquitous and determining IgG is not a reliable method for CMV primary infection, therefore, it can be a source of heterogeneity in the current study.

In conclusion, the findings of the present study demonstrated that CMV infection could be a potential risk for developing PE. More epidemiological studies (especially longitudinal studies using both molecular and serological methods) are needed to investigate the impact of CMV infection or its eradication on the risk of developing PE. Besides, more experimental studies should be done to identify the exact involved pathways. The GRADE for this study is this fact that further researches are very likely to have an important impact on our estimated effect and is likely to change the estimate.
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